Spravato is the brand name for the esketamine based nasal spray. Esketamine is similar to ketamine, and Spravato was FDA-approved in 2019 for treatment-resistant major depression as well as suicidal ideation. Since Spravato has been FDA approved for over 5 years now, it’s common to wonder just how much the first legal psychedelic medicine costs. …
Ketamine therapy is becoming an increasingly popular treatment for people with depression who can’t find relief from other medications. The treatment involves receiving low doses of ketamine multiple times a week for 2-3 weeks. It’s often coupled with therapy to help individuals achieve breakthroughs and solidify ketamine’s antidepressant effects. After a successful treatment, people typically …
Depression affects millions of people worldwide—impacting over 20 million adults and adolescents in the United States alone. While many people respond to conventional mental health treatments, research shows that 10-30% of individuals with depression see little to no improvement. However, a ground-breaking new treatment called Spravato™ (esketamine) offers hope for those who haven’t found success …
When the FDA approved the fast-acting esketamine nasal spray Spravato™ in early 2019, it gave newfound hope to many people who struggle with treatment-resistant depression (TRD), or any major depressive disorder that hasn’t improved with traditional antidepressants. As a fully certified ketamine clinic, Bespoke Treatment is committed to providing innovative and individualized solutions for patients with TRD, including in-office esketamine treatments. Let’s explore …
Bespoke Treatment focuses on non-medication treatments that work. We are the first boutique center in Southern California to specialize in personalized TMS therapy, Ketamine treatment, and psychiatry.
